Fidelity® SAI Intl Low Volatil Idx (FSKLX)
10.23
-0.06 (-0.58%)
USD |
Aug 18 2022
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 0.17% | 5.933B | 2.74% | 26.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| 725.99M | -11.80% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks to provide investment results that correspond to the total return of low volatility foreign stocks. The fund normally invests at least 80% of assets in equity securities included in the Fidelity International Low Volatility Focus Index℠, which reflects the performance of a broad range of equities across developed markets that in the aggregate have lower volatility relative to the broader foreign developed equity markets. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | FSKLX |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Category Name | Foreign Large Blend |
| Category Index | MSCI ACWI Ex USA NR USD |
| Prospectus Objective | Foreign Stock |
| Fund Owner Firm Name | Fidelity Investments |
| Prospectus Benchmark Index | |
| Fidelity Intl Low Vol Focus USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
| Manager Tenure | |
| Louis Bottari | 7.18 yrs |
| Peter Matthew | 7.18 yrs |
| Robert Regan | 5.59 yrs |
| Payal Gupta | 3.09 yrs |
| Navid Sohrabi | 2.92 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
13
725.99M
-3.186B
Category Low
14.73B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of July 31, 2022
Performance Versus Category
As of August 18, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of August 18, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
|
AstraZeneca PLC
|
2.10% | -- | -- |
|
Novo Nordisk A/S Class B
|
2.04% | -- | -- |
|
Novartis AG
|
2.03% | -- | -- |
|
Sanofi SA
|
1.98% | -- | -- |
|
Roche Holding AG
|
1.96% | -- | -- |
|
Nestle SA
|
1.91% | -- | -- |
|
Diageo PLC
|
1.83% | -- | -- |
|
RELX PLC
|
1.79% | -- | -- |
|
Nippon Telegraph & Telephone Corp
|
1.74% | -- | -- |
|
L'Oreal SA
|
1.73% | -- | -- |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | -- |
| Actual Management Fee | Upgrade |
| Administration Fee | -- |
| Performance Fee | -- |
| Switching Fee | -- |
| Transaction Fee | -- |
| Maximum Front Load | -- |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
Basic Info
| Investment Strategy | |
| The investment seeks to provide investment results that correspond to the total return of low volatility foreign stocks. The fund normally invests at least 80% of assets in equity securities included in the Fidelity International Low Volatility Focus Index℠, which reflects the performance of a broad range of equities across developed markets that in the aggregate have lower volatility relative to the broader foreign developed equity markets. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | FSKLX |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | International Equity |
| Broad Category | Equity |
| Category Name | Foreign Large Blend |
| Category Index | MSCI ACWI Ex USA NR USD |
| Prospectus Objective | Foreign Stock |
| Fund Owner Firm Name | Fidelity Investments |
| Prospectus Benchmark Index | |
| Fidelity Intl Low Vol Focus USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSACXUSNTR | 100.0% |
| Manager Tenure | |
| Louis Bottari | 7.18 yrs |
| Peter Matthew | 7.18 yrs |
| Robert Regan | 5.59 yrs |
| Payal Gupta | 3.09 yrs |
| Navid Sohrabi | 2.92 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (8-18-22) | 2.74% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 17.26 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of June 30, 2022
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 5/29/2015 |
| Last Annual Report Date | 10/31/2021 |
| Last Prospectus Date | 12/30/2021 |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund |
|
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |